New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
XOMA Corporation
XOMA
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

341M

Biotechnology

Next Earning date - 05 Nov 2024

341M

Biotechnology

Next Earning date - 05 Nov 2024

29.12USD
Shape0.47 ( 1.64%)
favorite-chart

Relative Strenght

82
favorite-chart

Volume Buzz

-60%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

5%

Quote Panel

Shape
Updated October 24, 2024
1W -0.95 % 1M 11.53 % 3M 0.69 % 1Y 65.64 %

Key Metrics

Shape
  • Market Cap

    340.84M


  • Shares Outstanding

    11.70M


  • Share in Float

    11.64M


  • Dividende

    2.16


  • Earning Date

    05 Nov 2024


  • Price Target

    29.12


  • Average Volume

    21971


  • Beta

    0.917


  • Range

    14.27-30.5


  • Industry

    Biotechnology


  • Website

    https://www.xoma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

22.37x

P/S Ratio

3.39x

P/B Ratio

1.2

Debt/Equity

-119.6%

Net Margin

$-2.2

EPS

How XOMA compares to sector?

P/E Ratio

Relative Strength

Shape

XOMA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$34M

Shape204%

2025-Revenue

$0.59

Shape-167%

2025-EPS

$7M

Shape-591%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.48
vs -0.51

Q4.22

arrow
arrow

N/A

-0.64
vs 1.67

Q1.23

arrow
arrow

N/A

-0.98
vs -0.32

Q2.23

arrow
arrow

N/A

-0.59
vs -0.53

Q3.23

arrow
arrow

N/A

-0.60
vs -0.48

Q4.23

arrow
arrow

N/A

-0.49
vs -0.64

Q1.24

arrow
arrow

N/A

-0.86
vs -0.98

Q2.24

arrow
arrow

N/A

-0.28
vs -0.59

Q3.24

arrow
arrow

N/A

-0.44
vs -0.60

Q4.24

arrow
arrow

N/A

-0.39
vs -0.49

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-52%

451K  vs 940K

Q4.22

arrow
arrow

-96%

1.5M  vs 35.9M

Q1.23

arrow
arrow

-86%

437K  vs 3.1M

Q2.23

arrow
arrow

+69%

1.7M  vs 983K

Q3.23

arrow
arrow

+84%

830K  vs 451K

Q4.23

arrow
arrow

+23%

1.8M  vs 1.5M

Q1.24

arrow
arrow

+241%

1.5M  vs 437K

Q2.24

arrow
arrow

+569%

11.1M  vs 1.7M

Q3.24

arrow
arrow

+684%

6.5M  vs 830K

Q4.24

arrow
arrow

+275%

6.9M  vs 1.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-3%

-0.03
vs -0.04

Q4.22

arrow
arrow

-5%

-0.05
vs -0.03

Q1.23

arrow
arrow

-15%

-0.15
vs -0.05

Q2.23

arrow
arrow

-5%

-0.05
vs -0.15

Q3.23

arrow
arrow

-5%

-0.05
vs -0.05

Q4.23

arrow
arrow

-23%

-0.23
vs -0.05

Q1.24

arrow
arrow

-10%

-0.10
vs -0.23

Q2.24

arrow
arrow

+16%

0.16
vs -0.10

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

43

43
vs 42

2%

Q4.22

arrow
arrow

50

50
vs 43

16%

Q1.23

arrow
arrow

52

52
vs 50

4%

Q2.23

arrow
arrow

60

60
vs 52

15%

Q3.23

arrow
arrow

54

54
vs 60

-10%

Q4.23

arrow
arrow

61

61
vs 54

13%

Q1.24

arrow
arrow

59

59
vs 61

-3%

Q2.24

arrow
arrow

61

61
vs 59

3%

Earnings Growth

Latest News